Nevro to Present at Truist Securities MedTech Conference
Nevro to Present at Truist Securities MedTech Conference
REDWOOD CITY, Calif., June 11, 2024 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain, today announced that members of its management team will participate in a "fireside chat" (question-and-answer) session at the Truist Securities MedTech Conference on Tuesday, June 18, 2024, beginning at approximately 8:40 am EDT.
全球医疗器械公司Nevro Corp. (纽交所:nevro)将于2024年6月18日星期二早上8:40参加Truist Securities MedTech大会的“炉边谈话”(问答)环节。
A live webcast of the session and a replay of the webcast will be available on the Events and Presentations page in the Investors section of the company's website at .
现场网络直播和重播将在该公司网站投资者部分的活动和演示页面上提供。
Internet Posting of Information
信息的互联网发布
Nevro routinely posts information that may be important to investors in the "Investor Relations" section of its website at . The company encourages investors and potential investors to consult the Nevro website regularly for important information about Nevro.
Nevro定期在其网站投资者关系部分发布可能对投资者重要的信息。该公司鼓励投资者和潜在投资者经常查看Nevro网站以获取重要信息。关于Nevro
About Nevro
Nevro总部位于加利福尼亚州Redwood City，是一家全球医疗器械公司，专注于提供全面、能够改变生活的治疗方案，为慢性疼痛的治疗开创了标准。该公司创立的最初宗旨是帮助更多患有疼痛的病人，并发展出了其专有的10 kHz疗法，这是一种以证据为基础的非药物创新，已经在全球影响了超过115000名患者的生活。Nevro全面的HFX脊髓神经刺激 (SCS)平台包括Senza SCS系统和支持慢性躯干和肢体疼痛及痛性糖尿病神经病变的治疗的支持服务。
Headquartered in Redwood City, California, Nevro is a global medical device company focused on delivering comprehensive, life-changing solutions that continue to set the standard for enduring patient outcomes in chronic pain treatment. The company started with a simple mission to help more patients suffering from debilitating pain and developed its proprietary 10 kHz Therapy, an evidence-based, non-pharmacologic innovation that has impacted the lives of more than 115,000 patients globally. Nevro's comprehensive HFX spinal cord stimulation (SCS) platform includes the Senza SCS system and support services for the treatment of chronic pain of the trunk and limb and painful diabetic neuropathy.
Nevro最近增加了治疗慢性骶髂关节疼痛的微创治疗选项，现在提供了SI关节融合空间中最全面的产品组合，旨在满足医生的偏好和不同的患者需求，以提高患者的治疗效果和生活质量。
Nevro recently added a minimally invasive treatment option for patients suffering from chronic sacroiliac joint ("SI joint") pain and now provides the most comprehensive portfolio of products in the SI joint fusion space, designed to meet the preferences of physicians and varying patient needs in order to improve outcomes and quality of life for patients.
Senza、Senza II、Senza Omnia、和HFX iQ是唯一提供Nevro专有10kHz疗法的SCS系统。Nevro独特的支持服务为每个病人提供HFX教练支持，以促进他们的止痛旅程，为每个医生提供HFX云洞察以增强患者和实践管理。
Senza, Senza II, Senza Omnia, and HFX iQ are the only SCS systems that deliver Nevro's proprietary 10 kHz Therapy. Nevro's unique support services provide every patient with HFX Coach support throughout their pain relief journey and every physician with HFX Cloud insights for enhanced patient and practice management.
SENZA、SENZA II、SENZA OMNIA、OMNIA、HF10、HF10标志、10 kHz疗法、HFX、HFX标志、HFX iQ、HFX iQ标志、HFX算法、HFX CONNECT、HFX Connect标志、HFX ACCESS、HFX Access标志、HFX COACH、HFX Coach标志、HFX CLOUD、HFX Cloud标志、RELIEF MULTIPLIED、X标志、NEVRO、和NEVRO标志是Nevro Corp.的商标或注册商标。涵盖Senza HFX iQ和其他Nevro产品的专利列在Nevro.com/patents想要了解更多有关Nevro的内容，请在Angie McCabe
SENZA, SENZA II, SENZA OMNIA, OMNIA, HF10, the HF10 logo, 10 kHz Therapy, HFX, the HFX logo, HFX iQ, the HFX iQ logo, HFX Algorithm, HFX CONNECT, the HFX Connect logo, HFX ACCESS, the HFX Access logo, HFX COACH, the HFX Coach logo, HFX CLOUD, the HFX Cloud logo, RELIEF MULTIPLIED, the X logo, NEVRO, and the NEVRO logo are trademarks or registered trademarks of Nevro Corp. Patents covering Senza HFX iQ and other Nevro products are listed at Nevro.com/patents.
副总裁，投资者关系&nevro.com/专利.
To learn more about Nevro, connect with us on LinkedIn, X, Facebook, and Instagram.
Nevro公司。LinkedIn, X, Facebook和Instagram.
Investors and Media:
Angie McCabe
Vice President, Investor Relations &
Corporate Communications
[email protected]
投资者和媒体:
安吉·麦凯比
投资者关系副总裁&
企业通讯
[email protected]
SOURCE Nevro Corp.
来源：Nevro公司。